Last update 23 Jan 2025
Ono Pharma Korea Co., Ltd.

Ono Pharma Korea Co., Ltd.

Subsidiary Company|
2013|
Seoul, South Korea
|
1,000-5,000
|
www.onopharma.co.kr

Overview

Tags

Skin and Musculoskeletal Diseases
Neoplasms
Cardiovascular Diseases
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Neoplasms2
Immune System Diseases2
Hemic and Lymphatic Diseases2
Endocrinology and Metabolic Disease1
Nervous System Diseases1
Top 5 Drug TypeCount
Small molecule drug2
Top 5 TargetCount
BRAF(Serine/threonine-protein kinase B-raf)1
BTK(Tyrosine-protein kinase BTK)1

Related

2
Drugs associated with Ono Pharma Korea Co., Ltd.
Tirabrutinib Hydrochloride
Target
BTK
Mechanism
BTK inhibitors
Active Org.
Ono Pharma Korea Co., Ltd.Ono Pharma Korea Co., Ltd. [+1]
Originator Org.
Ono Pharmaceutical Co., Ltd.Ono Pharmaceutical Co., Ltd.
Active Indication
Waldenstrom Macroglobulinemia [+3]
Inactive Indication
Chronic Lymphocytic Leukemia [+4]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
JP
First Approval Date25 Mar 2020
Encorafenib
Target
BRAF
Mechanism
BRAF inhibitors
Active Org.
Pfizer Inc.Pfizer Inc. [+9]
Originator Org.
Array BioPharma, Inc.Array BioPharma, Inc.
Active Indication
BRAF mutated anaplastic thyroid cancer [+23]
Inactive Indication
Glioblastoma Harboring BRAF V600 Mutation [+5]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
US
First Approval Date27 Jun 2018
1
Clinical Trials associated with Ono Pharma Korea Co., Ltd.
NCT04061863
/ Unknown statusPhase 1/2IIT
A Phase IB/II, Single Arm, Multi-center Study of Nivolumab in Combination With Eribulin in HER2 Negative Metastatic Breast Cancer Patients
100 Clinical Results associated with Ono Pharma Korea Co., Ltd.
Login to view more data
0 Patents (Medical) associated with Ono Pharma Korea Co., Ltd.
Login to view more data
100 Deals associated with Ono Pharma Korea Co., Ltd.
Login to view more data
100 Translational Medicine associated with Ono Pharma Korea Co., Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 31 Jan 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Approved
2
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Encorafenib
 ( BRAF )		BRAF V600E mutant Colorectal Cancer
More
Approved
Tirabrutinib Hydrochloride
 ( BTK )		Primary Central Nervous System Lymphoma
More
Approved
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free